Показано 0 из 0
Дата |
---|
18:40 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.61
|
1.62
|
1.73
|
1.60
|
1.73
|
1.6194
|
|
|
244 589.78
|
801.00
|
1.52
|
1.60
|
1.55
|
1.51
|
1.63
|
1.56
|
|
|
490 354.11
|
2 067.00
|
1.56
|
1.64
|
1.46
|
1.38
|
1.60
|
1.53
|
|
|
1 369 371.26
|
3 643.00
|
1.40
|
1.53
|
1.49
|
1.39
|
1.58
|
1.42
|
|
|
835 289.46
|
2 493.00
|
1.40
|
1.44
|
1.49
|
1.38
|
1.53
|
1.48
|
|
|
876 037.79
|
3 218.00
|
1.45
|
1.47
|
1.43
|
1.43
|
1.51
|
1.47
|
|
|
434 497.12
|
1 969.00
|
1.40
|
1.49
|
1.53
|
1.40
|
1.5428
|
1.43
|
|
|
547 902.73
|
2 356.00
|
1.48
|
1.55
|
1.61
|
1.47
|
1.65
|
1.50
|
|
|
713 305.39
|
3 495.00
|
1.63
|
1.64
|
1.71
|
1.60
|
1.73
|
1.63
|
|
|
546 839.54
|
2 234.00
|
1.69
|
1.75
|
1.77
|
1.69
|
1.79
|
1.72
|
|
|
574 379.28
|
1 945.00
|
Immuneering Corp is a biopharmaceutical company focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides computational biology capabilities to leading pharmaceutical and biotechnology companies.